{
  "zolgensma": {
    "condition": "spinal muscular atrophy",
    "approval_status": "FDA approved",
    "type": "AAV gene therapy (in vivo)",
    "developer": "Novartis",
    "age_group": "pediatric"
  },
  "luxturna": {
    "condition": "RPE65 mutation retinal dystrophy",
    "approval_status": "FDA approved",
    "type": "AAV gene therapy (in vivo)",
    "developer": "Spark Therapeutics",
    "age_group": "pediatric"
  },
  "elevidys": {
    "condition": "duchenne muscular dystrophy",
    "approval_status": "FDA approved",
    "type": "AAV gene therapy (in vivo)",
    "developer": "Sarepta Therapeutics",
    "age_group": "pediatric"
  },
  "roctavian": {
    "condition": "hemophilia A",
    "approval_status": "FDA approved",
    "type": "AAV gene therapy (in vivo)",
    "developer": "BioMarin",
    "age_group": "adult"
  },
  "adstiladrin": {
    "condition": "non-muscle invasive bladder cancer",
    "approval_status": "FDA approved",
    "type": "gene therapy (nadofaragene firadenovec-vncg)",
    "developer": "Ferring Pharmaceuticals",
    "age_group": "adult"
  },
  "kymriah": {
    "condition": "b-cell acute lymphoblastic leukemia",
    "approval_status": "FDA approved",
    "type": "CAR-T cell therapy",
    "developer": "Novartis",
    "age_group": "pediatric"
  },
  "yescarta": {
    "condition": "large b-cell lymphoma",
    "approval_status": "FDA approved",
    "type": "CAR-T cell therapy",
    "developer": "Gilead Sciences",
    "age_group": "adult"
  },
  "breyanzi": {
    "condition": "large b-cell lymphoma",
    "approval_status": "FDA approved",
    "type": "CAR-T cell therapy",
    "developer": "Bristol Myers Squibb",
    "age_group": "adult"
  },
  "ide-cel": {
    "condition": "multiple myeloma",
    "approval_status": "FDA approved",
    "type": "CAR-T cell therapy",
    "developer": "Bristol Myers Squibb",
    "age_group": "adult"
  },
  "betibeglogene autotemcel": {
    "condition": "beta-thalassemia",
    "approval_status": "Phase I/II",
    "type": "lentiviral gene therapy (ex vivo)",
    "developer": "bluebird bio",
    "age_group": "pediatric"
  },
  "amyt-101": {
    "condition": "x-linked hypohidrotic ectodermal dysplasia",
    "approval_status": "Phase I",
    "type": "gene therapy (preclinical AAV)",
    "developer": "Amryt Pharma",
    "age_group": "pediatric"
  }
}
